Log in | Create new account Free!
Report Overview:
The Global 3D Cell Culture Market achieved a valuation of $1040.75 Million in 2022 and is anticipated to exceed $3183.68 Million by 2030, reflecting a compounded annual growth rate (CAGR) of 15% during the forecast period from 2024 to 2032.
Key Market Players:
Report Overview:
The Global Heart Failure POC & LOC Devices Market achieved a valuation of $63.91 Million in 2022 and is anticipated to exceed $212.40 Million by 2030, reflecting a compounded annual growth rate (CAGR) of 16.2% during the forecast period from 2024 to 2032.
Key Market Players:
Abbott, Danahar, Siemens Healthineers, and F. Hoffmann-La Roche Ltd. Other emerging players such as Quidel Corporation, bioMérieux S.A, Trinity BiotechInstrumentation Laboratory, and Abaxis, Inc
Report Overview:
The Global Genomics in Cancer Care Market achieved a valuation of $13.91 Billion in 2022 and is anticipated to exceed $45.27 Billion by 2030, reflecting a compounded annual growth rate (CAGR) of 15.9% during the forecast period from 2024 to 2032.
Key Market Players:
Agilent Technologies, Illumina, Inc., Pacific Biosciences, Inc., ThermoFisher Scientific Inc., Intrexon Bioinformatics Germany GmbH
Report Overview:
The Global Medical Workstations Market achieved a valuation of $4.28 Billion in 2022 and is anticipated to exceed $7.41 Billion by 2030, reflecting a compounded annual growth rate (CAGR) of 7.1% during the forecast period from 2024 to 2032.
Key Market Players:
Report Overview:
The Global Healthcare Cybersecurity Market achieved a valuation of $12.96 Billion in 2022 and is anticipated to exceed $48.05 Billion by 2030, reflecting a compounded annual growth rate (CAGR) of 17.8% during the forecast period from 2024 to 2032.
Key Market Players:
Cisco Systems Inc. (US), IBM Corporation (US), Kaspersky Labs Inc (Russia), Broadcom Inc. (US), McAfee Inc. (US).
Report Overview:
The Global Reprocessed Medical Devices Market achieved a valuation of $2.29 Billion in 2022 and is anticipated to exceed $6.72 Billion by 2030, reflecting a compounded annual growth rate (CAGR) of 14.4% during the forecast period from 2024 to 2032.
Key Market Players:
GE Healthcare, Medline Industries, Renu Medical (Arjo), Soma Technology, Stryker, Teleflex Incorporated, Medtronic, Innovative Health, Vanguard AG, Ethicon, and SureTek Medical.
Report Overview:
The Global Tele Intensive Care Unit Market achieved a valuation of $3.48 Billion in 2022 and is anticipated to exceed $11.43 Billion by 2030, reflecting a compounded annual growth rate (CAGR) of 16% during the forecast period from 2024 to 2032.
Key Market Players:
Inova (US), INTeLeICU (India), InTouch Technologies Inc. (US), Koninklijke Philips NV (Netherlands), Advanced ICU Care (US).
Report Overview:
The Global Clinical Communication and Collaboration Market achieved a valuation of $2.34 Billion in 2022 and is anticipated to exceed $8.32 Billion by 2030, reflecting a compounded annual growth rate (CAGR) of 17.2% during the forecast period from 2024 to 2032.
Key Market Players:
Spok Inc.; Cerner Corporation; Hill Room Services, Inc.; Vocera Communications; and Cisco Systems Inc.
Report Overview:
The Global ICU Beds Market achieved a valuation of $1672.65 Million in 2022 and is anticipated to exceed $2471.28 Million by 2030, reflecting a compounded annual growth rate (CAGR) of 5% during the forecast period from 2024 to 2032.
Key Market Players:
DSV Panalpina A/S (Span-America Medical Systems, Inc.), Hill-Rom Holdings Inc., Getinge AB, Joh. Stiegelmeyer & Co. GmbH (Stiegelmeyer GmbH & Co. KG), Invacare Corporation, Malvestio S.P.A., Linet Group SE (Linet spol. s.r.o.), Merivaara Corp., Medline Industries Inc., Stryker Corporation
Report Overview:
The Global Platelet Aggregation Devices Market achieved a valuation of $532.56 Million in 2022 and is anticipated to exceed $868.23 Million by 2030, reflecting a compounded annual growth rate (CAGR) of 6.3% during the forecast period from 2024 to 2032.
Key Market Players:
Bio/Data Corporation (US), Helena Laboratories Corporation (US), WerfenLife (Spain),F.Hoffmann-La Roche Ltd (Switzerland), Siemens Healthineers AG (Germany).
